238 related articles for article (PubMed ID: 22374405)
1. Alternatives to standard unfractionated heparin for pediatric hemodialysis treatments.
Davenport A
Pediatr Nephrol; 2012 Oct; 27(10):1869-79. PubMed ID: 22374405
[TBL] [Abstract][Full Text] [Related]
2. Rationale and design of the HepZero study: a prospective, multicenter, international, open, randomized, controlled clinical study with parallel groups comparing heparin-free dialysis with heparin-coated dialysis membrane (Evodial) versus standard care: study protocol for a randomized controlled trial.
Rossignol P; Dorval M; Fay R; Ros JF; Loughraieb N; Moureau F; Laville M
Trials; 2013 Jun; 14():163. PubMed ID: 23725299
[TBL] [Abstract][Full Text] [Related]
3. What are the anticoagulation options for intermittent hemodialysis?
Davenport A
Nat Rev Nephrol; 2011 Jul; 7(9):499-508. PubMed ID: 21727925
[TBL] [Abstract][Full Text] [Related]
4. Unfractionated heparin for hemodialysis: still the best option.
Cronin RE; Reilly RF
Semin Dial; 2010; 23(5):510-5. PubMed ID: 21039876
[TBL] [Abstract][Full Text] [Related]
5. Use and safety of unfractionated heparin for anticoagulation during maintenance hemodialysis.
Shen JI; Winkelmayer WC
Am J Kidney Dis; 2012 Sep; 60(3):473-86. PubMed ID: 22560830
[TBL] [Abstract][Full Text] [Related]
6. Review: anticoagulation for haemodialysis.
Suranyi M; Chow JS
Nephrology (Carlton); 2010 Jun; 15(4):386-92. PubMed ID: 20609088
[TBL] [Abstract][Full Text] [Related]
7. Evaluation with micro-CT of different anticoagulation strategies during hemodialysis in patients with thrombocytopenia: A randomized crossover study.
Vanommeslaeghe F; De Somer F; Josipovic I; Boone M; Dhondt A; Van Biesen W; Eloot S
Artif Organs; 2019 Aug; 43(8):756-763. PubMed ID: 30820962
[TBL] [Abstract][Full Text] [Related]
8. [Anticoagulation of the extracorporeal circuit in chronic hemodialysis].
Ryckelynck JP; Chouraqui D; Lobbedez T
Nephrologie; 1998; 19(4):223-5. PubMed ID: 9675763
[TBL] [Abstract][Full Text] [Related]
9. Laboratory Monitoring of Heparin Anticoagulation in Hemodialysis: Rationale and Strategies.
Chiasakul T; Mullier F; Lecompte T; Nguyen P; Cuker A
Semin Nephrol; 2023 Nov; 43(6):151477. PubMed ID: 38290962
[TBL] [Abstract][Full Text] [Related]
10. Citrate compared to low molecular weight heparin anticoagulation in chronic hemodialysis patients.
Janssen MJ; Deegens JK; Kapinga TH; Beukhof JR; Huijgens PC; van Loenen AC; van der Meulen J
Kidney Int; 1996 Mar; 49(3):806-13. PubMed ID: 8648924
[TBL] [Abstract][Full Text] [Related]
11. Essentials of anticoagulation in hemodialysis.
Fischer KG
Hemodial Int; 2007 Apr; 11(2):178-89. PubMed ID: 17403168
[TBL] [Abstract][Full Text] [Related]
12. The safety of heparins in end-stage renal disease.
Sonawane S; Kasbekar N; Berns JS
Semin Dial; 2006; 19(4):305-10. PubMed ID: 16893408
[TBL] [Abstract][Full Text] [Related]
13. An evaluation of four modes of low-dose anticoagulation during intermittent haemodialysis.
Skagerlind MSE; Stegmayr BG
Eur J Clin Pharmacol; 2018 Mar; 74(3):267-274. PubMed ID: 29198062
[TBL] [Abstract][Full Text] [Related]
14. Old and new heparins.
Cosmi B; Palareti G
Thromb Res; 2012 Mar; 129(3):388-91. PubMed ID: 22137740
[TBL] [Abstract][Full Text] [Related]
15. A noninferiority trial comparing a heparin-grafted membrane plus citrate-containing dialysate versus regional citrate anticoagulation: results of the CiTED study.
Meijers B; Metalidis C; Vanhove T; Poesen R; Kuypers D; Evenepoel P
Nephrol Dial Transplant; 2017 Apr; 32(4):707-714. PubMed ID: 28407129
[TBL] [Abstract][Full Text] [Related]
16. A significant proportion of patients treated with citrate containing dialysate need additional anticoagulation.
Stegmayr BG; Jonsson P; Mahmood D
Int J Artif Organs; 2013 Jan; 36(1):1-6. PubMed ID: 23280073
[TBL] [Abstract][Full Text] [Related]
17. Parenteral anticoagulants: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
Hirsh J; Bauer KA; Donati MB; Gould M; Samama MM; Weitz JI
Chest; 2008 Jun; 133(6 Suppl):141S-159S. PubMed ID: 18574264
[TBL] [Abstract][Full Text] [Related]
18. Anticoagulation options for intermittent haemodialysis.
Davenport A
Minerva Urol Nefrol; 2006 Jun; 58(2):171-80. PubMed ID: 16767070
[TBL] [Abstract][Full Text] [Related]
19. The rationale for the use of low molecular weight heparin for hemodialysis treatments.
Davenport A
Hemodial Int; 2013 Oct; 17 Suppl 1():S28-32. PubMed ID: 24134328
[TBL] [Abstract][Full Text] [Related]
20. Dermatan sulfate: an alternative to unfractionated heparin for anticoagulation in hemodialysis patients.
Vitale C; Berutti S; Bagnis C; Soragna G; Gabella P; Fruttero C; Marangella M
J Nephrol; 2013; 26(1):158-63. PubMed ID: 22419236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
